<VariationArchive VariationID="1438062" VariationName="NM_000212.3(ITGB3):c.55del (p.Ala19fs)" VariationType="Deletion" Accession="VCV001438062" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-30" DateCreated="2022-03-28" MostRecentSubmission="2024-06-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1510799" VariationID="1438062">
      <GeneList>
        <Gene Symbol="ITGB3" FullName="integrin subunit beta 3" GeneID="3690" HGNC_ID="HGNC:6156" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47253827" stop="47313743" display_start="47253827" display_stop="47313743" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45331207" stop="45390076" display_start="45331207" display_stop="45390076" Strand="+" />
          </Location>
          <OMIM>173470</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ITGB3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000212.3(ITGB3):c.55del (p.Ala19fs)</Name>
      <CanonicalSPDI>NC_000017.11:47253911:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="47253912" stop="47253912" display_start="47253912" display_stop="47253912" variantLength="1" positionVCF="47253911" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="45331278" stop="45331278" display_start="45331278" display_stop="45331278" variantLength="1" positionVCF="45331277" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_000212.3(ITGB3):c.55del</Name>
        <Name>p.Ala19fs</Name>
      </OtherNameList>
      <ProteinChange>A19fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.45331282del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.45331282del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.47253916del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.47253916del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008332.2" sequenceAccession="NG_008332" sequenceVersion="2" change="g.5075del">
            <Expression>NG_008332.2:g.5075del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000212.3" sequenceAccession="NM_000212" sequenceVersion="3" change="c.55del" MANESelect="true">
            <Expression>NM_000212.3:c.55del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000203.2" sequenceAccession="NP_000203" sequenceVersion="2" change="p.Ala19fs">
            <Expression>NP_000203.2:p.Ala19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_481" sequenceAccession="LRG_481">
            <Expression>LRG_481:g.5075del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1302506624" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000212.3(ITGB3):c.55del (p.Ala19fs) AND not provided" Accession="RCV001948884" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000212.3(ITGB3):c.55del (p.Ala19fs) AND Glanzmann thrombasthenia" Accession="RCV004577558" Version="1">
        <ClassifiedConditionList TraitSetID="734">
          <ClassifiedCondition DB="MedGen" ID="C0040015">Glanzmann thrombasthenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2024-02-20" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-06-23">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">21917754</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/7fdd5fd0-80ed-4c6f-b3f7-adbd891c8ae7</URL>
        </Citation>
        <DescriptionHistory Dated="2024-06-22">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3893" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann's thrombasthenia</ElementValue>
                <XRef ID="Thrombasthenia+of+Glanzmann+and+Naegeli/7074" DB="Genetic Alliance" />
                <XRef ID="32942005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia of Glanzmann and Naegeli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia</ElementValue>
                <XRef ID="MONDO:0100326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann thrombasthenia type A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diacyclothrombopathia 2B 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2478" />
                <XRef ID="2478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="849" DB="Orphanet" />
              <XRef ID="C0040015" DB="MedGen" />
              <XRef ID="MONDO:0100326" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS273800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4230860" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="7610495|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002213175" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21917754</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1438062). This variant has not been reported in the literature in individuals affected with ITGB3-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Ala19Argfs*7) in the ITGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ITGB3 are known to be pathogenic (PMID: 21917754).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.45331278del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="9831558" SubmissionDate="2024-06-18" DateLastUpdated="2024-06-23" DateCreated="2024-06-23">
        <ClinVarSubmissionID localKey="7fdd5fd0-80ed-4c6f-b3f7-adbd891c8ae7" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005061663" DateUpdated="2024-06-23" DateCreated="2024-06-23" Type="SCV" Version="1" SubmitterName="ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen" OrgID="507662" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-20">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Uncertain Significance</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/7fdd5fd0-80ed-4c6f-b3f7-adbd891c8ae7</URL>
          </Citation>
          <Comment>The c.55del variant in ITGB3 is a deletion of 1 nucleotide in exon 1, resulting in a shift of the reading frame and a premature stop signal (p.Ala19Argfs*7). Premature termination codon within exon 1/ first 100 nucleotides may not cause NMD and instead may lead to translation re-initiation (PMID: 27618451). Therefore, PVS1 is downgraded to PVS1_moderate. This variant occurs at a very low allele frequency overall in gnomAD v4.0.0 of 0.000006374 with a MAF of 0.000002980 (3/1006570) in the non-Finnish European population (PM2_Supporting). The variant has been reported heterozygous in one individual (PMID: 31980526) but has not been reported in any patients with a Glanzmann thrombasthenia phenotype. In summary, this variant meets the criteria to be classified as uncertain significance for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1_Moderate, PM2_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Platelet ACMG Specifications v2-1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/mac6zhy2/clingen_platelet_acmg_specifications_v2-1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000212.3(ITGB3):c.55del</Name>
            <Name>p.Ala19fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.47253916del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100326" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14546493</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4230860" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9831558" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100326" MappingRef="MONDO">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

